United States Pharmaceuticals

Shuttle Pharmaceuticals Holdings Inc (SHPH)

Track

Track

Shuttle Pharmaceuticals Holdings Inc. experienced eleven transactions d'initiés over the past ninety days, all executed by HRT Financial LP. These activities resulted in a net negative value of approximately $318,243. While the stock price declined 6.1% recently, no further results financiers are expected until September 2026, reflecting current market volatility for this healthcare entity.
Ticker: SHPH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Shuttle Pharmaceuticals Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Sale
Price
274.72
Quantity 53,732 +25.9%
Value US$3,399,231
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Sale
Price
108.39
Quantity 82,979 -4.5%
Value US$3,782,040
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Purchase
Price
202.10
Quantity 492 -27.3%
Value US$4,272,741
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Purchase
Price
3.38
Quantity 8,266 +15.8%
Value US$27,939
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Sale
Price
3.52
Quantity 18,531 -26.2%
Value US$65,229
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Sale
Price
3.33
Quantity 10,580 -13.0%
Value US$35,231
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Sale
Price
3.51
Quantity 9,022 -10.0%
Value US$31,667
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Purchase
Price
3.54
Quantity 7,851 +9.5%
Value US$27,793
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Purchase
Price
3.30
Quantity 3,959 +5.0%
Value US$13,065
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Purchase
Price
3.23
Quantity 6,755 +9.4%
Value US$21,819
2.6
HRT FINANCIAL LP Large shareholder
Transaction date
Purchase
Price
3.44
Quantity 25,836 +56.2%
Value US$88,876
2.6
Brown Milton Non-Executive Director
Transaction date
Sale
Price
0.46
Quantity 2,921 -0.3%
Value US$1,353
2.3
Jacobs Bette Non-Executive Director
Transaction date
Sale
Price
0.46
Quantity 4,157 -13.3%
Value US$1,926
1.6
Senanayake Chris Non-Executive Director
Transaction date
Sale
Price
1.61
Quantity 1,626 -36.8%
Value US$2,610
1.6
Richards Steven M Non-Executive Director
Transaction date
Sale
Price
1.61
Quantity 995 -36.8%
Value US$1,597
2.6
Brown Milton Non-Executive Director
Transaction date
Sale
Price
1.61
Quantity 995 -0.1%
Value US$1,597
1.6
Adkins William
Transaction date
Sale
Price
1.61
Quantity 995 -0.5%
Value US$1,597
2.3
Jacobs Bette Non-Executive Director
Transaction date
Sale
Price
1.61
Quantity 4,366 -12.3%
Value US$7,007
1.6
Jung Mira Chief Scientific Officer Officer
Transaction date
Sale
Price
1.61
Quantity 328 -0.0%
Value US$526
1.6
Dritschilo Anatoly CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
1.61
Quantity 8,372 -0.8%
Value US$13,437
1.6
Rich Tyvin Chief Medical Officer Officer
Transaction date
Sale
Price
1.61
Quantity 1,414 -36.8%
Value US$2,269
1.6
Vander Hoek Michael Chief Financial Officer Officer
Transaction date
Sale
Price
1.61
Quantity 2,243 -36.8%
Value US$3,600
1.6
Dritschilo Peter President and COO Officer
Transaction date
Sale
Price
1.61
Quantity 3,820 -36.8%
Value US$6,131
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-14 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
53,732 +25.9%
274.72
US$3,399,231 		53,732 +25.9% 274.72 US$3,399,231
2026-07-15 2026-07-13 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
82,979 -4.5%
108.39
US$3,782,040 		82,979 -4.5% 108.39 US$3,782,040
2026-07-13 2026-07-10 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
492 -27.3%
202.10
US$4,272,741 		492 -27.3% 202.10 US$4,272,741
2026-07-13 2026-07-09 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
8,266 +15.8%
3.38
US$27,939 		8,266 +15.8% 3.38 US$27,939
2026-07-09 2026-07-08 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
18,531 -26.2%
3.52
US$65,229 		18,531 -26.2% 3.52 US$65,229
2026-07-09 2026-07-07 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
10,580 -13.0%
3.33
US$35,231 		10,580 -13.0% 3.33 US$35,231
2026-07-07 2026-07-06 S Sale
2.6
HRT FINANCIAL LP
Large shareholder
9,022 -10.0%
3.51
US$31,667 		9,022 -10.0% 3.51 US$31,667
2026-07-07 2026-07-02 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
7,851 +9.5%
3.54
US$27,793 		7,851 +9.5% 3.54 US$27,793
2026-07-02 2026-07-01 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
3,959 +5.0%
3.30
US$13,065 		3,959 +5.0% 3.30 US$13,065
2026-07-01 2026-06-30 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
6,755 +9.4%
3.23
US$21,819 		6,755 +9.4% 3.23 US$21,819
2026-07-01 2026-06-29 B Purchase
2.6
HRT FINANCIAL LP
Large shareholder
25,836 +56.2%
3.44
US$88,876 		25,836 +56.2% 3.44 US$88,876
2024-01-02 2023-12-13 S Sale
2.6
Brown Milton
Non-Executive Director
2,921 -0.3%
0.46
US$1,353 		2,921 -0.3% 0.46 US$1,353
2023-12-20 2023-12-13 S Sale
2.3
Jacobs Bette
Non-Executive Director
4,157 -13.3%
0.46
US$1,926 		4,157 -13.3% 0.46 US$1,926
2024-03-14 2022-12-29 S Sale
1.6
Senanayake Chris
Non-Executive Director
1,626 -36.8%
1.61
US$2,610 		1,626 -36.8% 1.61 US$2,610
2023-01-09 2022-12-29 S Sale
1.6
Richards Steven M
Non-Executive Director
995 -36.8%
1.61
US$1,597 		995 -36.8% 1.61 US$1,597
2023-01-04 2022-12-29 S Sale
2.6
Brown Milton
Non-Executive Director
995 -0.1%
1.61
US$1,597 		995 -0.1% 1.61 US$1,597
2023-01-04 2022-12-29 S Sale
1.6
Adkins William
995 -0.5%
1.61
US$1,597 		995 -0.5% 1.61 US$1,597
2023-01-03 2022-12-29 S Sale
2.3
Jacobs Bette
Non-Executive Director
4,366 -12.3%
1.61
US$7,007 		4,366 -12.3% 1.61 US$7,007
2023-01-03 2022-12-29 S Sale
1.6
Jung Mira

Chief Scientific Officer

Officer
328 -0.0%
1.61
US$526 		328 -0.0% 1.61 US$526
2023-01-03 2022-12-29 S Sale
1.6
Dritschilo Anatoly

CEO and Chairman

Executive Director Large shareholder
8,372 -0.8%
1.61
US$13,437 		8,372 -0.8% 1.61 US$13,437
2023-01-03 2022-12-29 S Sale
1.6
Rich Tyvin

Chief Medical Officer

Officer
1,414 -36.8%
1.61
US$2,269 		1,414 -36.8% 1.61 US$2,269
2022-12-30 2022-12-29 S Sale
1.6
Vander Hoek Michael

Chief Financial Officer

Officer
2,243 -36.8%
1.61
US$3,600 		2,243 -36.8% 1.61 US$3,600
2022-12-30 2022-12-29 S Sale
1.6
Dritschilo Peter

President and COO

Officer
3,820 -36.8%
1.61
US$6,131 		3,820 -36.8% 1.61 US$6,131
Explore more

More insider trading research around Shuttle Pharmaceuticals Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America